Dependent Controlled Substance Transparency Act

Bill 118 s 3638, also known as the Dependent Controlled Substance Transparency Act, is a piece of legislation currently being considered by the US Congress. The main purpose of this bill is to increase transparency and accountability in the distribution of controlled substances to dependents.

Under this proposed law, healthcare providers who prescribe controlled substances to dependents, such as minors or individuals with disabilities, would be required to report detailed information about these prescriptions to a centralized database. This database would be accessible to law enforcement agencies, healthcare providers, and other authorized parties in order to monitor and track the distribution of these substances.

The bill also includes provisions to ensure that healthcare providers are properly trained in identifying and addressing potential issues of substance abuse or misuse among dependents. Additionally, it aims to improve communication and coordination between healthcare providers, pharmacies, and law enforcement agencies to prevent the diversion of controlled substances to unauthorized individuals. Overall, the Dependent Controlled Substance Transparency Act seeks to address the growing concerns surrounding the misuse and abuse of controlled substances among dependents by promoting greater transparency, accountability, and collaboration among key stakeholders in the healthcare system.